Product Information
DOXYCYCLINE IR-DR 40 MG CAP is a generic product labeled by Apotex Corp., priced at $4.6707 per EA under NDC 60505477503. Its NADAC has been published 99 times since Nov 13, 2024.
FDA first approved this application on Jul 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Apotex Corp.NDC
60505477503
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA217170FDA Approved
7/11/2024
TE Code
AB
On Market Since
10/31/2024
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE IR-DR 40 MG CAP has been published 99 times since Nov 13, 2024, and over the history we have for it it has declined 76.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6707 per EA |
|---|---|
| All-time high | $20.2350 (Nov 13, 2024) |
| All-time low | $4.2949 (Aug 19, 2026) |
| 52-week high | $11.3939 |
| 52-week low | $4.2949 |
| Median price | $10.3910 |
| Average price | $10.8039 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 99 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE IR-DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE IR-DR 40 MG CAP, manufactured by Apotex Corp., is $4.6707 per EA (NDC 60505477503), effective Sep 30, 2026.
How has the price of DOXYCYCLINE IR-DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has declined 76.9%. It has been tracked across 99 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE IR-DR 40 MG CAP?
Since Nov 13, 2024, the NADAC for DOXYCYCLINE IR-DR 40 MG CAP has ranged from a low of $4.2949 (Aug 19, 2026) to a high of $20.2350 (Nov 13, 2024), with a median of $10.3910 per EA.
Are there cheaper alternatives to DOXYCYCLINE IR-DR 40 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE IR-DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE IR-DR 40 MG CAP?
DOXYCYCLINE IR-DR 40 MG CAP (NDC 60505477503) is labeled by Apotex Corp., and CMS classifies it as a generic product.